JANUS BIOTHERAPEUTICS INC has a total of 27 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GLICK GARY D, BAYER YAKUHIN LTD and FERROKIN BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Israel | 2 | |
#8 | Brazil | 1 | |
#9 | India | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zepp Charles M | 25 |
#2 | Lipford Grayson B | 25 |
Publication | Filing date | Title |
---|---|---|
CN107108629A | Novel N2, N4, N7, the 6 quaternary triamines of pteridine 2,4,7 and 2,4,6,7 quaternary pteridine compounds and its synthesis and application method | |
AU2012318694A1 | Novel imidazole quinoline-based immune system modulators | |
AU2012262021A1 | Novel immune system modulators | |
CN103717070A | Novel immune system modulators |